Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACE | P12821 | 3/20 | 0.68 |
| ▸ | ECE1 | P42892 | 12/20 | 0.63 |
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.62 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29696985 | 0.96 | ACE (0.65) | ACEECE1ERAP2ALOX15 | |
| SCHEMBL31696723 | 0.94 | ACE (0.60) | ACEECE1ERAP2 | |
| SCHEMBL29488096 | 0.94 | ACE (0.60) | ACEECE1ERAP2 | |
| SCHEMBL29536181 | 0.93 | ACE (0.69) | ACEECE1ERAP2ALOX15 | |
| SCHEMBL30051087 | 0.92 | ACE (0.75) | ACEECE1ERAP2ALOX15 | |
| SCHEMBL9235805 | 0.92 | ACE (0.78) | ACEECE1ALOX15 | |
| SCHEMBL2488765 | 0.92 | ACE (0.78) | ACEECE1ALOX15 | |
| SCHEMBL1228369 | 0.92 | ACE (0.78) | ACEECE1ALOX15 | |
| SCHEMBL9235801 | 0.92 | ACE (0.78) | ACEECE1ALOX15 | |
| SCHEMBL29400177 | 0.92 | ACE (0.78) | ACEECE1ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12578345-B2 | Single molecule peptide sequencing | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2026-03-17 | — | — | US | disclosed |
| US-12379381-B2 | Single molecule peptide sequencing | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2025-08-05 | — | — | US | disclosed |
| US-20240302380-A1 | SINGLE MOLECULE PEPTIDE SEQUENCING | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2024-09-12 | — | — | US | disclosed |
| US-20240272146-A1 | CHROMOGENIC AND FLUOROGENIC COMPOUNDS AND THEIR USE FOR BIOLOGICAL DETECTION | AAT BIOQUEST, INC. | 2024-08-15 | — | — | US | disclosed |
| US-20230107647-A1 | SINGLE MOLECULE PEPTIDE SEQUENCING | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2023-04-06 | — | — | US | disclosed |
| US-11435358-B2 | Single molecule peptide sequencing | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2022-09-06 | — | — | US | disclosed |
| US-20220091130-A1 | SINGLE MOLECULE PEPTIDE SEQUENCING | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM | 2022-03-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230107647-A1 | SINGLE MOLECULE PEPTIDE SEQUENCING | QPCTL, ANPEP, VIP | ACE 1689/4885ECE1 1401/4885ERAP2 831/4885 |
| US-11435358-B2 | Single molecule peptide sequencing | QPCTL, ANPEP, VIP | ACE 1717/4885ECE1 1371/4885ERAP2 842/4885 |
| US-12379381-B2 | Single molecule peptide sequencing | MICA, ANPEP, DNPEP | ACE 3263/4885ECE1 1286/4885ERAP2 1026/4885 |
| US-12578345-B2 | Single molecule peptide sequencing | SET, PTMS, MICA | ACE 2836/4885ECE1 3977/4885ERAP2 2803/4885 |
| US-20240272146-A1 | CHROMOGENIC AND FLUOROGENIC COMPOUNDS AND THEIR USE FOR BIOLOGICAL DETECTION | ANTXR2, CDYL, VIP | ACE 297/4885ECE1 543/4885ERAP2 671/4885 |
| US-20240302380-A1 | SINGLE MOLECULE PEPTIDE SEQUENCING | QPCTL, ANPEP, VIP | ACE 1689/4885ECE1 1401/4885ERAP2 831/4885 |
| US-20220091130-A1 | SINGLE MOLECULE PEPTIDE SEQUENCING | QPCTL, ANPEP, VIP | ACE 1689/4885ECE1 1401/4885ERAP2 831/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.